| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.5M | -80.4% | -91.4% |
| R&D Expense | $2.9M | -60.0% | -93.3% |
| SG&A Expense | $4.0M | -38.8% | -61.7% |
| Operating Income | -$3.6M | -211.8% | +83.6% |
| Interest Expense | $909K | -6.5% | -23.2% |
| Pre-tax Income | -$4.3M | -278.9% | +80.5% |
| Income Tax | $28K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $5.7M | -66.0% | -87.6% |
| Short-term Investments | $8.0M | +47.0% | -61.6% |
| Accounts Receivable | $1.9M | — | +43.3% |
| Inventory | $0 | — | -100.0% |
| Current Assets | $18.4M | -25.6% | -79.9% |
| Total Assets | $30.2M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$45.2M | — | — |
| Capital Expenditures | $0 | — | — |
| Investing Cash Flow | $9.7M | — | — |
| Financing Cash Flow | $16.1M | — | — |
| Free Cash Flow | -$45.2M | — | — |
| +833.3% |
| +264.7% |
| Net Income | -$4.3M | -280.3% | +80.4% |
| EPS (Basic) | -$0.32 | -260.0% | +89.1% |
| EPS (Diluted) | -$0.32 | -268.4% | +89.1% |
| -18.3% |
| -78.9% |
| Current Liabilities | $18.1M | +24.0% | -88.4% |
| Total Liabilities | $66.8M | -7.1% | -71.4% |
| Stockholders' Equity | -$36.6M | -4.5% | +59.5% |